Replies to post #499978 on NorthWest Biotherapeutics Inc (NWBO)

[Horseb4CarT]

Ike are you considering revenue in the UK beginning now and ramping up?

[hoffmann6383]

Hey Ike,

Agree on the 2b. That sounds reasonable. I'll take your word on the 10-60. That number is definitely in the DGCL and I believe you when you say it is also in NWBO'S bylaws.

Also agree that setting expectations that don't pan out can be harmful. On the flip side, can you blame someone for being excited about their investment and someone that has faith that their dd will turn out to be correct?! I also believe some wolves in sheep skin set these same expectations hoping they fail and it leads to a sell off. It's a fine line we balance here.

Lastly, I don't think you are some short and sometimes I can be brash in my responses and I apologize for that :)

Have a good one.

[iwasadiver]

I spoke to the company regarding the Series C preferred. It was my understanding that if I bought some there would be a 3 month hold from conversion from the time the notice was put out in the 8-K. That’s all I know for ME. I don’t know if there will be separate or different terms for others, just what I was told in regard to my purchase.

As far as “speculation”; this company has one product that is only being manufactured for compassionate use in one little country. Everything about this stock is speculative, everything. And we speculate on this board, that’s what it’s about because anything else that’s known for sure is public. So what you may consider “wild” speculation others may feel is honest and intelligent speculation.

I believe I’ve read the bread crumbs, the tea leaves, the public statements, and have used them as well as conversations I’ve had with company management to understand fairly well their strategies, their way of thinking, the mistakes they’ve made, the mistakes they’ve fixed, etc. to speculate pretty wisely. I was in when the stock topped out at $12 and bought back in at .14-.19 heavily based on what I perceived was happening. And I was correct.

I “speculate” that these 10 million shares will be sold to some investors such as myself and some other larger share holders to raise a couple million dollars in the short term. Then the others could be one of several things or a combination of things.

1. The shares, with voting power, is, I believe, meant as protection from a hostile takeover by a Pharma that knows retail feels exhausted and could low ball an offer that might make a majority agree to a shit deal.

1.a. Those shares could be given to management as part of their allowed for compensation and give them the power to prevent 1.
1.b. Some of those shares could go to CRL as part of a general manufacturing agreement to broaden the availability of production.
1.c. Some could go to a big fund who wants to partner to raise capital to do further trials to broaden the scope of DCVax for all solid tumors
1.d. Some could go to a Pharma who’s seeing some failures in their Oncology division and wants to be part of the show, having the clinical trial capabilities to do the same as mentioned in 1.c.

I see nothing “wild” about any of these speculations what so ever. And I like to share what I’m thinking and see what others see or feel.